References
- 1 British Society of Gastroenterology .Guidelines for the diagnosis and management
of Barrett’s columnar-lined oesophagus. 2005. Available from: URL: http://www.bsg.org.uk/
- 2
Sampliner R E.
Updated guidelines for the diagnosis, surveillance, and therapy of Barrett’s esophagus.
Am J Gastroenterol.
2002;
97
1888-1895
- 3
Vieth M, Kiesslich R.
Distinction of high-grade intraepithelial neoplasia and invasive Barrett’s adenocarcinoma.
Esophagus.
2006;
3
171-176
- 4
Schnell T G, Sontag S J, Chejfec G. et al .
Long-term nonsurgical management of Barrett’s esophagus with high-grade dysplasia.
Gastroenterology.
2001;
120
1607-1619
- 5
Sharma P, Weston A P, Topalovski M. et al .
Magnification chromoendoscopy for the detection of intestinal metaplasia and dysplasia
in Barrett’s oesophagus.
Gut.
2003;
52
24-27
- 6
Sharma P, Marcon N, Wani S. et al .
Non-biopsy detection of intestinal metaplasia and dysplasia in Barrett’s esophagus:
a prospective multicenter study.
Endoscopy.
2006;
38
1206-1212
- 7
Egger K, Meining A, Werner M. et al .
Biopsy surveillance is still necessary in patients with Barrett’s oesophagus despite
new endoscopic imaging techniques.
Gut.
2003;
52
18-23
- 8
O’Connor J B, Falk G W, Richter J E.
The incidence of adenocarcinoma and dysplasia in Barrett’s esophagus: report on the
Cleveland Clinic Barrett’s Esophagus Registry.
Am J Gastroenterol.
1999;
94
2037-2042
- 9
Csendes A, Smok G, Burdiles P. et al .
Prevalence of intestinal metaplasia according to the length of the specialized columnar
epithelium lining the distal esophagus in patients with gastroesophageal reflux.
Dis Esophagus.
2003;
16
24-28
- 10
Gopal D V, Lieberman D A, Magaret N. et al .
Risk factors for dysplasia in patients with Barrett’s esophagus (BE): results from
a multicenter consortium.
Dig Dis Sci.
2003;
48
1537-1541
- 11
Conio M, Blanchi S, Lapertosa G. et al .
Long-term endoscopic surveillance of patients with Barrett’s esophagus. Incidence
of dysplasia and adenocarcinoma: a prospective study.
Am J Gastroenterol.
2003;
98
1931-1939
- 12
Vieth M, Stolte M.
Barrett’s esophagus and neoplasia: data from the Bayreuth Barrett’s archive.
Gastroenterology.
2002;
122
590-591
- 13
Montgomery E, Bronner M P, Goldblum J R. et al .
Reproducibility of the diagnosis of dysplasia in Barrett’s esophagus: a reaffirmation.
Hum Pathol.
2001;
32
368-378
- 14
Skacel M, Petras R E, Gramlich T L. et al .
The diagnosis of low-grade dysplasia in Barrett’s esophagus and its implications for
disease progression.
Am J Gastroenterol.
2000;
95
3383-3387
- 15
Weston A P, Badr A S, Hassanein R S.
Prospective multivariate analysis of clinical, endoscopic, and histological factors
predictive of the development of Barrett’s multifocal high-grade dysplasia or adenocarcinoma.
Am J Gastroenterol.
1999;
94
3413-3419
- 16
Sharma P, Falk G W, Westen A P. et al .
Dysplasia and cancer in a large multicenter cohort of patients with Barrett’s esophagus.
Clin Gastroenterol Hepatol.
2006;
4
566-572
- 17
Lim C H, Treanor D, Dixon M F, Axon A TR.
Low-grade dysplasia in Barrett’s esophagus has a high risk of progression.
Endoscopy.
2007;
39
581-587
- 18
Vieth M, Schubert B, Lang-Schwarz K. et al .
Frequency of Barrett’s neoplasia after initial negative endoscopy with biopsy: a long-term
histopathological follow-up study.
Endoscopy.
2006;
38
1201-1205
- 19
Sharma P, Dent J, Armstrong D. et al .
The development and validation of an endoscopic grading system for Barrett’s esophagus:
the Prague C & M criteria.
Gastroenterology.
2006;
131
1392-1399
- 20
Spechler S J.
Clinical practice: Barrett’s esophagus.
N Engl J Med.
2002;
346
836-842
- 21
Pech O, Vieth M, Schmitz D. et al .
Conclusions from the histological diagnosis of low-grade intraepithelial neoplasia
in Barrett’s oesophagus.
Scand J Gastroenterol.
2007;
42
682-688
M. Vieth, MD
Institute of Pathology
Klinikum Bayreuth
Preuschwitzer Str. 101
95445 Bayreuth
Germany
Fax: +49-921-400-5609
Email: vieth.lkpathol@uni-bayreuth.de
